Tempus Announces the National Launch of FDA-Approved xT CDx Test
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Too Old to Operate3 小时
Role of CDKN2A and MTF1 in Lung Adenocarcinoma Prognosis
The following is a summary of “Biological characterization and clinical significance of cuproptosis-related genes in lung ...
Healio5 小时
Real-world outcomes with bispecific T-cell engagers in lymphoma worse than pivotal trials
Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings ...
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was ...
The Scientist9 小时
An Exosome Protein Sets the Stage for a Cancer Biomarker
Many cancers upregulate an amino acid transporter to fuel their growth, making this protein a promising tool in tumor ...
Investors Eye Biotech Stocks as Cancer Therapies Take Center Stage in 2025
USA News Group News Commentary – As the new year begins, the American Association for Cancer Research (AACR) has highlighted ...
Enzo Biochem, Inc.: Enzo Biochem Receives Notice of Non-Compliance with New York Stock ...
Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company") today announced that it was notified by the New York Stock Exchange (the "NYSE") that it is ...
gut.bmj21 小时
Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes ...
In the present study the effect of SCFA on LL-37 expression was investigated. Methods: LL-37 expression in vivo was assessed by immunohistochemistry. Real time quantitative reverse ...